Read our latest advice on Coronavirus (COVID-19)

Our services are open and safe to attend – we are here to help

Cutaneous allergy research



Coronavirus: dermatology update

In response to the coronavirus (COVID-19) outbreak, please read our advice and information.

Our research

Clinical research in this area includes the identification of new allergens and studies looking at the epidemiology of contact allergy. Data from our studies are fed into European institutions to influence the control and elimination of allergens on the consumer market.

Recent projects include evaluation of the impact of isothiazolinone contact allergy in Europe and demonstrating the importance of aromatic substance allergy on eczema and quality of life.

Find out more about our open and completed clinical trials





There are a number of studies currently open actively looking for recruits.

For more information about our trials or if you are interested in taking part, please email dermatologytrials@

I would definitely recommend taking part in research… new treatments need patient involvement and I wanted to help others in the future

Jane Johnston, a participant in one of our clinical trials